Access the full text.
Sign up today, get DeepDyve free for 14 days.
Hagerstoten (1999)
American society for colposcopy and cervical pathology.Journal of lower genital tract disease, 3 2
S. Isidean, M. Mayrand, A. Ramanakumar, L. Gilbert, S. Reid, Isabel Rodrigues, A. Ferenczy, S. Ratnam, F. Coutlée, E. Franco (2016)
Human papillomavirus testing versus cytology in primary cervical cancer screening: End‐of‐study and extended follow‐up results from the Canadian cervical cancer screening trialInternational Journal of Cancer, 139
G. Ho, R. Bierman, L. Beardsley, C. Chang, R. Burk (1998)
Natural history of cervicovaginal papillomavirus infection in young women.The New England journal of medicine, 338 7
R. Luttmer, M. Dijkstra, P. Snijders, J. Berkhof, F. Kemenade, L. Rozendaal, T. Helmerhorst, R. Verheijen, W. Harmsel, W. Baal, P. Graziosi, W. Quint, J. Spruijt, D. Dijken, Daniëlle Heideman, Chris Meijer (2016)
p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient populationModern Pathology, 29
C. Racey, Diana Withrow, D. Gesink (2013)
Self-collected HPV Testing Improves Participation in Cervical Cancer Screening: A Systematic Review and Meta-analysisCanadian Journal of Public Health, 104
Michelle Khan, P. Castle, A. Lorincz, S. Wacholder, M. Sherman, David Scott, B. Rush, A. Glass, M. Schiffman (2005)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.Journal of the National Cancer Institute, 97 14
M. Arbyn, G. Ronco, A. Anttila, C. Meijer, M. Poljak, G. Ogilvie, G. Koliopoulos, P. Nauclér, R. Sankaranarayanan, J. Peto (2012)
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.Vaccine, 30 Suppl 5
C. Piyathilake, M. Macaluso, R. Alvarez, Min Chen, Suguna Badiga, J. Edberg, E. Partridge, G. Johanning (2011)
A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasiaCancer, 117
N. Wentzensen, B. Fetterman, P. Castle, M. Schiffman, Shannon Wood, Eric Stiemerling, D. Tokugawa, C. Bodelón, N. Poitras, T. Lorey, W. Kinney (2015)
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.Journal of the National Cancer Institute, 107 12
L. Strooper, V. Verhoef, J. Berkhof, A. Hesselink, Helena Bruin, F. Kemenade, R. Bosgraaf, R. Bekkers, L. Massuger, Willem Melchers, R. Steenbergen, P. Snijders, Chris Meijer, Daniëlle Heideman (2016)
Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive womenGynecologic Oncology, 141
P. Vassilakos, D. Schwartz, F. Marval, L. Yousfi, G. Broquet, F. Mathez-Loic, A. Campana, A. Major (2000)
Biopsy-based comparison of liquid-based, thin-layer preparations to conventional Pap smears.The Journal of reproductive medicine, 45 1
R. Baars, J. Marel, P. Snijders, Agata Rodriquez-Manfredi, B. Harmsel, H. Munckhof, J. Ordi, M. Pino, M. Sandt, N. Wentzensen, C. Meijer, W. Quint (2016)
CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsiesInternational Journal of Cancer, 138
W. Huh, E. Williams, Joice Huang, T. Bramley, N. Poulios (2014)
Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer ScreeningApplied Health Economics and Health Policy, 13
G. Zielinski, P. Snijders, L. Rozendaal, N. Daalmeijer, E. Risse, F. Voorhorst, N Jiwa, H. Linden, F. Schipper, A. Runsink, C. Meijer (2003)
The presence of high‐risk HPV combined with specific p53 and p16INK4a expression patterns points to high‐risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervixThe Journal of Pathology, 201
M. Rodríguez-Paredes, M. Esteller (2011)
Cancer epigenetics reaches mainstream oncologyNature Medicine
Y. Ouh, Jae Lee (2018)
Proposal for cervical cancer screening in the era of HPV vaccinationObstetrics & Gynecology Science, 61
A. Hesselink, Daniëlle Heideman, R. Steenbergen, M. Gök, F. Kemenade, S. Wilting, J. Berkhof, C. Meijer, P. Snijders (2014)
Methylation marker analysis of self‐sampled cervico‐vaginal lavage specimens to triage high‐risk HPV‐positive women for colposcopyInternational Journal of Cancer, 135
A. Virmani, C. Muller, A. Rathi, S. Zoechbauer-Mueller, M. Mathis, A. Gazdar (2001)
Aberrant methylation during cervical carcinogenesis.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 3
H. Katki, W. Kinney, B. Fetterman, T. Lorey, N. Poitras, L. Cheung, F. Demuth, M. Schiffman, S. Wacholder, P. Castle (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.The Lancet. Oncology, 12 7
V. Verhoef, D. Heideman, F. Kemenade, L. Rozendaal, R. Bosgraaf, A. Hesselink, R. Bekkers, L. Massuger, R. Steenbergen, P. Snijders, J. Berkhof, C. Meijer (2014)
Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.Gynecologic oncology, 135 1
M. Kalantari, Itzel Calleja-Macias, D. Tewari, B. Hagmar, K. Lie, H. Barrera-Saldana, D. Wiley, H. Bernard (2004)
Conserved Methylation Patterns of Human Papillomavirus Type 16 DNA in Asymptomatic Infection and Cervical NeoplasiaJournal of Virology, 78
G. Ronco, J. Dillner, K. Elfström, S. Tunesi, P. Snijders, M. Arbyn, H. Kitchener, N. Segnan, C. Gilham, P. Giorgi-Rossi, J. Berkhof, J. Peto, C. Meijer (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsThe Lancet, 383
W. Tjalma, Emily Kim, K. Vandeweyer (2017)
The impact on women's health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium.European journal of obstetrics, gynecology, and reproductive biology, 212
S. Vinokurova, N. Wentzensen, I. Kraus, R. Klaes, Corina Driesch, P. Melsheimer, F. Kisseljov, M. Dürst, A. Schneider, M. Doeberitz (2008)
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.Cancer research, 68 1
R. Al-Awadhi, W. Chehadeh, Mohammad Jaragh, Azza Al-Shaheen, Prem Sharma, K. Kapila (2013)
Distribution of human papillomavirus among women with abnormal cervical cytology in KuwaitDiagnostic Cytopathology, 41
D. Saslow, D. Solomon, H. Lawson, M. Killackey, S. Kulasingam, J. Cain, Francisco Garcia, A. Moriarty, A. Waxman, D. Wilbur, N. Wentzensen, L. Downs, M. Spitzer, A. Moscicki, E. Franco, M. Stoler, M. Schiffman, P. Castle, E. Myers (2012)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerCA: A Cancer Journal for Clinicians, 62
S. Galván, M. Martínez-Salazar, Víctor Galván, Rocío Méndez, Gibrán Díaz-Contreras, Moisés Alvarado-Hermida, Rogelio Alcántara-Silva, A. García-Carrancá (2011)
Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomesBMC Genomics, 12
R. Luttmer, L. Strooper, M. Dijkstra, J. Berkhof, P. Snijders, R. Steenbergen, F. Kemenade, L. Rozendaal, T. Helmerhorst, R. Verheijen, W. Harmsel, W. Baal, P. Graziosi, W. Quint, J. Spruijt, D. Dijken, Daniëlle Heideman, C. Meijer (2016)
FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive womenBritish Journal of Cancer, 115
S. Bulk, N. Bulkmans, J. Berkhof, L. Rozendaal, A. Boeke, R. Verheijen, P. Snijders, C. Meijer (2007)
Risk of high‐grade cervical intra‐epithelial neoplasia based on cytology and high‐risk HPV testing at baseline and at 6‐monthsInternational Journal of Cancer, 121
O. Abulafia, J. Pezzullo, D. Sherer (2003)
Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey.Gynecologic oncology, 90 1
M. Arbyn, F. Verdoodt, P. Snijders, V. Verhoef, Eero Suonio, L. Dillner, S. Minozzi, Cristina Bellisario, R. Banzi, F. Zhao, P. Hillemanns, A. Anttila (2014)
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.The Lancet. Oncology, 15 2
N. Muñoz, F. Bosch, S. Sanjosé, R. Herrero, X. Castellsagué, K. Shah, P. Snijders, C. Meijer (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer.The New England journal of medicine, 348 6
A. Rodriguez, M. Schiffman, R. Herrero, S. Wacholder, A. Hildesheim, P. Castle, D. Solomon, R. Burk (2008)
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.Journal of the National Cancer Institute, 100 7
P. Castle, M. Stoler, T. Wright, Abha Sharma, TeresaL Wright, C. Behrens (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.The Lancet. Oncology, 12 9
G. Ho, R. Burk, S. Klein, A. Kadish, C. Chang, P. Palan, J. Basu, R. Tachezy, Renée Lewis, S. Romney (1995)
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.Journal of the National Cancer Institute, 87 18
J. Walboomers, M. Jacobs, M. Manos, F. Bosch, J. Kummer, K. Shah, P. Snijders, J. Peto, C. Meijer, N. Muñoz (1999)
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 189
A. Hesselink, D. Heideman, R. Steenbergen, V. Coupé, R. Overmeer, D. Rijkaart, J. Berkhof, C. Meijer, P. Snijders (2011)
Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA–Positive WomenClinical Cancer Research, 17
M. Rebolj, E. Lynge, J. Bonde (2011)
Human papillomavirus testing and genotyping in cervical screeningExpert Review of Anticancer Therapy, 11
(2009)
p 16 ( INK 4 a ) immunostaining in cytological and histological specimens from the uterine cervix : a systematic review and meta - analysis
D. Cook, Wendy Mei, L. Smith, D. Niekerk, Kathy Ceballos, E. Franco, A. Coldman, G. Ogilvie, M. Krajden (2015)
Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trialBMC Cancer, 15
T. Wright, C. Behrens, J. Ranger-Moore, Susanne Rehm, Abha Sharma, M. Stoler, R. Ridder (2017)
Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.Gynecologic oncology, 144 1
E. Pirog, B. Lloveras, A. Molijn, S. Tous, N. Guimerà, M. Alejo, O. Clavero, J. Klaustermeier, D. Jenkins, W. Quint, F. Bosch, L. Alemany, S. Sanjosé (2014)
HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 casesModern Pathology, 27
R. Luttmer, L. Strooper, J. Berkhof, P. Snijders, M. Dijkstra, M. Uijterwaal, R. Steenbergen, F. Kemenade, L. Rozendaal, T. Helmerhorst, R. Verheijen, W. Harmsel, W. Baal, P. Graziosi, W. Quint, D. Heideman, C. Meijer (2016)
Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high‐risk HPV‐positive women of a gynecologic outpatient population (COMETH study)International Journal of Cancer, 138
K. Nanda, D. Mccrory, E. Myers, L. Bastian, V. Hasselblad, J. Hickey, D. Matchar (2001)
Accuracy of the Papanicolaou Test in Screening for and Follow‐up of Cervical Cytologic Abnormalities: A Systematic ReviewJournal of Lower Genital Tract Disease, 5
T. Wright, M. Stoler, C. Behrens, Abha Sharma, Guili Zhang, T. Wright (2015)
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.Gynecologic oncology, 136 2
L Mirabello, M Schiffman, A Ghosh, AC Rodriguez, N Vasiljevic, N Wentzensen (2013)
Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia, 132
V. Verhoef, F. Kemenade, L. Rozendaal, D. Heideman, R. Bosgraaf, A. Hesselink, W. Melchers, L. Massuger, R. Bekkers, R. Steenbergen, J. Berkhof, P. Snijders, C. Meijer (2015)
Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.Gynecologic oncology, 137 1
J. Gage, M. Schiffman, H. Katki, P. Castle, B. Fetterman, N. Wentzensen, N. Poitras, T. Lorey, L. Cheung, W. Kinney (2014)
Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.Journal of the National Cancer Institute, 106 8
(2008)
Use of p 16 - INK 4 A overexpression to increase the specificity of human papillomavirus testing : a nested substudy of the NTCC randomised controlled trial
S. Sanjosé, Wim Quint, L. Alemany, D. Geraets, J. Klaustermeier, B. Lloveras, S. Tous, A. Félix, Luis Bravo, Hai-rim Shin, Carlos Vallejos, Patricia Ruiz, Marcus Lima, N. Guimerà, O. Clavero, M. Alejo, A. Llombart-Bosch, Cheng‐Yang Chou, Silvio Tatti, Elena Kasamatsu, Ermina Iljazović, M. Odida, R. Prado, M. Seoud, M. Grce, A. Usubutun, Asha Jain, Gustavo Suarez, L. Lombardi, A. Banjo, C. Menéndez, E. Domingo, J. Velasco, A. Nessa, S. Chichareon, You-Lin Qiao, E. Lerma, S. Garland, T. Sasagawa, A. Ferrera, D. Hammouda, L. Mariani, A. Pelayo, I. Šteiner, E. Oliva, C. Meijer, W. Al-Jassar, E. Cruz, Thomas Wright, A. Puras, C. Llave, M. Tzardi, T. Agorastos, V. García-Barriola, C. Clavel, J. Ordi, M. Andujar, X. Castellsagué, G. Sánchez, A. Nowakowski, J. Bornstein, N. Muñoz, F. Bosch (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.The Lancet. Oncology, 11 11
S. Kjær, K. Frederiksen, C. Munk, T. Iftner (2010)
Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.Journal of the National Cancer Institute, 102 19
Jo‐Heon Kim, Y. Choi, J. Lee, Jae Lee, J. Nam, Chan Choi (2010)
Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.Gynecologic oncology, 116 1
G Ronco, J Dillner, KM Elfstrom, S Tunesi, PJ Snijders, M Arbyn (2014)
International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials, 383
A. Lorincz, A. Brentnall, D. Ścibior-Bentkowska, Caroline Reuter, R. Banwait, L. Cadman, J. Austin, J. Cuzick, Nataša Vasiljević (2016)
Validation of a DNA methylation HPV triage classifier in a screening sampleInternational Journal of Cancer, 138
J. Dillner, M. Rebolj, P. Birembaut, K. Petry, A. Szarewski, C. Munk, S. Sanjosé, P. Nauclér, B. Lloveras, S. Kjaer, J. Cuzick, M. Ballegooijen, C. Clavel, T. Iftner (2008)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyThe BMJ, 337
S. Wajed, P. Laird, T. Demeester (2001)
DNA Methylation: An Alternative Pathway to CancerAnnals of Surgery, 234
Nataša Vasiljević, P. Carter, Caroline Reuter, Rhian Warman, A. Brentnall, R. James, Carton, J. Cuzick, A. Lorincz (2018)
Role of quantitative p 16 ( INK 4 A ) mRNA assay and digital reading of p 16 ( INK 4 A ) immunostained sections in diagnosis of cervical intraepithelial
A. Renshaw, N. Young, G. Birdsong, P. Styer, D. Davey, D. Mody, T. Colgan (2004)
Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program.Archives of pathology & laboratory medicine, 128 1
C. Bergeron, H. Ikenberg, M. Sideri, K. Denton, J. Bogers, D. Schmidt, F. Alameda, T. Keller, Susanne Rehm, R. Ridder (2015)
Prospective evaluation of p16/Ki‐67 dual‐stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study resultsCancer Cytopathology, 123
The association between high-risk genotypes of human papillomavirus (hr-HPV) and cervical cancer is well established. As hr-HPV testing is rapidly becoming a part of routine cervical cancer screening, either in conjunction with cytology or as primary testing, the management of hr-HPV-positive women has to be tailored in a way that increases the detection of cervical abnormalities while decreasing unnecessary colposcopic biopsies or other invasive procedures. In this review, we discuss the overall utility and strategies of hr-HPV testing, as well as the advantages and limitations of potential triage strategies for hr-HPV-positive women, including HPV genotyping, p16/Ki-67 dual staining, and methylation assays.
Acta Cytologica – Karger
Published: Jan 1, 2020
Keywords: Cervical screening; High-risk human papillomavirus; Genotyping; Dual staining; Methylation
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.